Covid–19 pneumonia and MLS®: a successful case history

24 August 2020 - Research -

A very recent case report concerning the use of MLS® Laser Therapy supporting a patient suffering from severe pneumonia caused by Covid-19A 57-Year-Old African American Man with Severe COVID-19 Pneumonia Who Responded to Supportive Photobiomodulation Therapy (PBMT): First Use of PBMT in COVID-19 – reported a significant improvement in some basic parameters (breathing indexes, radiological results, oxygen requirement) for several days and without the need for a breathing ventilator.

Although future controlled clinical studies are required in order to assess the effect of laser therapy on the clinical results of patients with a similar pathology, the reported case is significant, particularly when looking at the specifics of the monitored parameters.

The results

Treated every day for 4 days with MLS®, the patient in fact recorded an increased saturation from 93–94% to 97–100%, a decreased oxygen requirement (the flow rate went from 2–4 L/min to 1 L/min) and a reduction of other respiratory indexes (Brescia-COVID and SMART-COP) from 4 to 0. Furthermore, the C-reactive protein normalised from 15.1 to 1.23 and the CAP tool score (a questionnaire which evaluates respiratory symptoms and well-being) showed a substantial improvement.

You might also be interested in ...

See all articles

press - 11/09/2020
The American portal Contagion® - Infectious Diseases Today, which collects all information concerning infectious diseases, records a recent case report dedicated to the use of MLS® Laser Therapy for...
press - 01/09/2020
The NBC Boston News channel presents an important case report which demonstrates how MLS® Laser Therapy, applied to a patient affected by Covid-19 in order to treat pulmonary infection, markedly...
First Use of PBMT in COVID-19
S.A. Sigman, S. Mokmeli, M. Monici, M. A. Vetrici American Journal of Case Reports, 21:e926779, 2020  This report has presented supportive PBMT in a patient with severe COVID-19 pneumonia....
ASA laserterapia en la Universidad Autonoma de Chile
News - 12/05/2022
The Universidad Autónoma de Chile and the Universidad Andrés Bello hosted two in-depth sessions dedicated to MLS® Laser Therapy as part of two seminars entitled respectively “Physical agents: the...
Press - 03/05/2022
"We have treated almost 40 patients with laser therapy and all of them have experienced an improvement in their condition” - Jana Mahdalíková
MLS Laser Therapy for Hypoxia/Ischemia-Induced Rod Microglia
Blog - 20/04/2022
This study lays the foundations for many research perspectives in the field of photobiomodulation using near infrared laser radiation (NIR) and demonstrates the effectiveness of MLS® and its MiS...